Kira Dies, ScM, CGC

Clinical Co-ordination Manager

Executive Director, Rosamund Stone Zander Translational Neuroscience Center
Boston Children’s Hospital.

Kira received her MS degree in Genetic Counseling in 2003 from the Johns Hopkins Bloomberg School of Public Health/National Human Genome Research Institute. She is board certified by the American Board of Genetic Counseling and a licensed genetic counselor in Massachusetts. Her experience includes serving as Director of the Family Research Network of the Autism Consortium, coordinating multi-site research and family resources. From 2008-2020, she worked at Boston Children’s Hospital in roles including Senior Genetic Counseling Program Manager and co-Director of Clinical Research Operations of the Translational Neuroscience Center, managing clinical research programs in Neurogenetics and providing clinical genetic counseling for patients in the Neurology department. In January 2021, she was promoted to become the Executive Director of the new Rosamund Stone Zander Translational Neuroscience Center at Boston Children’s Hospital. Additionally, since 2006, she served as a coordinator of the Research Seminar Series, aiding in the development of student thesis projects, at Boston University School of Medicine Genetic Counseling graduate program. She serves on the Board of Directors for the CureAP4 advocacy organization, the Professional Advisory Board for the Tuberous Sclerosis Alliance, the Clinical Ethics Board and Neuroscience Family Advisory Council at BCH. She has authored numerous publications regarding genetic susceptibility to autism and tuberous sclerosis complex as well as social issues in genetic counseling.